Drug and Medication Analysis & Statistics in the United Kingdom, October 2014 (p3)

You might be interested in: Drug, Vaccine, Smoking Cessation, more »

61-90 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Milnacipran  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Milnacipran - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Moxifloxacin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Moxifloxacin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Raltegravir  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Raltegravir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Ramelteon  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Ramelteon - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Remifentanil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Remifentanil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Sunitinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Sunitinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Tigecycline  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Tigecycline - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Cinacalcet  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Cinacalcet - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Clevidipine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Clevidipine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Saxagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Saxagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Vildagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Vildagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Nilotinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Nilotinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, United States, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, World
Perampanel  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Perampanel - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Orphan Drug Market Access: Payer Insights on the Present and Future

Orphan Drug Market Access: Payer Insights on the Present and Future

  • $ 531
  • Industry report
  • October 2014
  • by Firstword Pharma

Orphan Drug Market Access: Payer Insights on the Present and Future is a report that examines the regulation, pricing, reimbursement, players and stakeholder/payer interests that are shaping the current ...

  • Industries : Drug and Medication
  • Countries : United States, France, Europe, United Kingdom, Spain, Italy, Germany
uniPHARM Wholesale Drugs Ltd. SWOT Analysis, Strategy, Revenues and Profits

uniPHARM Wholesale Drugs Ltd. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : United States, Canada, United Kingdom
Teva UK Limited SWOT Analysis, Strategy, Revenues and Profits

Teva UK Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Mylan Pharma UK Limited - Strategic SWOT Analysis Review

Mylan Pharma UK Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Mylan is a pharmaceutical company. The company develops and supplies generic medicines. Its products include aceclofenac, aciclovir dispersible, alendronic acid, baclofen, beclometasone, beclometasone, ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
PharmaPoint: Acute Coronary Syndrome - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Acute Coronary Syndrome - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • July 2014
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - 5EU Drug Forecast and Market Analysis to 2023 Summary GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, France, Germany, United Kingdom, Europe, World
AstraZeneca UK Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

AstraZeneca UK Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary AstraZeneca UK Limited (AstraZeneca) is a pharmaceutical company. The company develops and markets medicines. Its products include exenatide prolonged-release suspension for injection, rosuvastatin, ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
MarketVIEW - Meningitis ACWY vaccines

MarketVIEW - Meningitis ACWY vaccines

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Gram-negative Neisseria meningitidis (N.men) is an important contributor to bacterial meningitis. Of the estimated 1.2 million cases which occur each year (WHO Figures), N.men is thought to be responsible ...

  • Industries : Drug and Medication
  • Countries : World, United States, Europe, Chile, South America, Saudi Arabia, Africa, United Kingdom, South Korea, Brazil, France, Asia, Argentina, Indonesia, Colombia, Mexico, Spain, Italy, Greece, Germany, Austria, Pakistan, Malaysia, North America
Contraception Market Report 2014

Contraception Market Report 2014

  • $ 898
  • Industry report
  • July 2014
  • by Key Note Publications Ltd

Executive Summary This Key Note Market Report analyses the contraception market in the UK, covering a wide range of contraceptive methods, including hormone-based products, such as oral contraceptives ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

BMI View: The UK faces its most uncertain period in a generation, as the Conservative-Liberal Democrat coalition presses ahead with fiscal cutbacks and constitutional reform. Plans to modernise the National ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Analgesics Market Analysis in the United Kingdom

Analgesics Market Analysis in the United Kingdom

  • $ 898
  • Industry report
  • May 2014
  • by Euromonitor International

Retail value sales of analgesics in the UK grew 1% in 2010 to reach GBP 533 million. This growth was higher than the increase of just under 1% seen in 2009. Consumers were looking for fast pain relief ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in the United Kingdom

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in the United Kingdom

  • $ 898
  • Industry report
  • May 2014
  • by Euromonitor International

In 2010 the cough cold and allergies environment grew by more than 2% in current value terms to reach a value of GBP 637 million. The incidence of cold and flu in 2009/2010 appeared to be lower than in ...

  • Industries : Drug and Medication, Tobacco
  • Countries : United Kingdom
NRT Smoking Cessation Aids Market Analysis in the United Kingdom

NRT Smoking Cessation Aids Market Analysis in the United Kingdom

  • $ 898
  • Industry report
  • May 2014
  • by Euromonitor International

Retail sales of NRT smoking cessation aids in the UK grew by 3% in current value terms in 2010 to reach GBP 111 million. The government’s spending cuts have had an indirect positive influence on the ...

  • Industries : Drug and Medication, Tobacco
  • Countries : United Kingdom
MarketVIEW: Group B Streptococcus

MarketVIEW: Group B Streptococcus

  • $ 4 495
  • Industry report
  • May 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Group B beta streptococci (GBS) or Streptococcus agalactiae is an encapsulated Gram-positive coccus capable of producing a range of diseases in humans of all age ranges. In the neonate, the bacterium can ...

  • Industries : Drug and Medication
  • Countries : United States, World, Australia, Africa, Brazil, Mexico, Canada, United Kingdom, Spain, Italy, France, Germany, Europe, North America
PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive ...

  • Industries : Drug and Medication
  • Countries : Italy, Spain, France, Germany, United Kingdom, Europe, World
Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022

Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which ...

  • Industries : Drug and Medication
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Nucynta ER/Palexia SR (Neuropathic Pain) - Forecast and Market Analysis to 2022

Nucynta ER/Palexia SR (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Nucynta ER/Palexia SR (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, France, Germany, World, United States, United Kingdom, Europe
Lidoderm/Versatis (Neuropathic Pain) - Forecast and Market Analysis to 2022

Lidoderm/Versatis (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Lidoderm/Versatis (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive ...

  • Industries : Drug and Medication
  • Countries : Germany, United States, World, Spain, Italy, France, Europe, United Kingdom
About 900 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Industry in the UK

  • Infection Report
  • November 2014
    7 pages
  • Drug And Medica...  

    Antibiotic  

  • United Kingdom  

    Europe  

View report >

Drug Industry In The Uk

November 2014

2 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Select Products Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.